AU2016302146B2 - Phenyl urea analogs as formyl peptide receptor 1 (FPR1) selective agonists - Google Patents

Phenyl urea analogs as formyl peptide receptor 1 (FPR1) selective agonists Download PDF

Info

Publication number
AU2016302146B2
AU2016302146B2 AU2016302146A AU2016302146A AU2016302146B2 AU 2016302146 B2 AU2016302146 B2 AU 2016302146B2 AU 2016302146 A AU2016302146 A AU 2016302146A AU 2016302146 A AU2016302146 A AU 2016302146A AU 2016302146 B2 AU2016302146 B2 AU 2016302146B2
Authority
AU
Australia
Prior art keywords
alkyl
disease
retinal
optionally substituted
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2016302146A
Other languages
English (en)
Other versions
AU2016302146A1 (en
Inventor
Richard L. Beard
Tien T. Duong
Michael E. Garst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU2016302146A1 publication Critical patent/AU2016302146A1/en
Priority to AU2020294291A priority Critical patent/AU2020294291A1/en
Application granted granted Critical
Publication of AU2016302146B2 publication Critical patent/AU2016302146B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2016302146A 2015-08-05 2016-08-02 Phenyl urea analogs as formyl peptide receptor 1 (FPR1) selective agonists Ceased AU2016302146B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2020294291A AU2020294291A1 (en) 2015-08-05 2020-12-24 Phenyl urea analogs as formyl peptide receptor 1 (FPR1) selective agonists

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562201387P 2015-08-05 2015-08-05
US62/201,387 2015-08-05
PCT/US2016/045114 WO2017023907A1 (en) 2015-08-05 2016-08-02 Phenyl urea analogs as formyl peptide repceptor 1 (fpr1) selective agonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2020294291A Division AU2020294291A1 (en) 2015-08-05 2020-12-24 Phenyl urea analogs as formyl peptide receptor 1 (FPR1) selective agonists

Publications (2)

Publication Number Publication Date
AU2016302146A1 AU2016302146A1 (en) 2018-02-08
AU2016302146B2 true AU2016302146B2 (en) 2021-01-28

Family

ID=56684759

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2016302146A Ceased AU2016302146B2 (en) 2015-08-05 2016-08-02 Phenyl urea analogs as formyl peptide receptor 1 (FPR1) selective agonists
AU2020294291A Abandoned AU2020294291A1 (en) 2015-08-05 2020-12-24 Phenyl urea analogs as formyl peptide receptor 1 (FPR1) selective agonists

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2020294291A Abandoned AU2020294291A1 (en) 2015-08-05 2020-12-24 Phenyl urea analogs as formyl peptide receptor 1 (FPR1) selective agonists

Country Status (7)

Country Link
US (1) US20200079729A1 (enExample)
EP (1) EP3331897B1 (enExample)
JP (2) JP6900365B2 (enExample)
AU (2) AU2016302146B2 (enExample)
CA (1) CA2992662A1 (enExample)
TW (1) TW201718473A (enExample)
WO (1) WO2017023907A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
TW201718473A (zh) * 2015-08-05 2017-06-01 歐樂根公司 作為甲醯肽受體１（ｆｐｒ１）選擇性促效劑之苯基脲類似物
ITUB20169937A1 (it) * 2016-01-12 2017-07-12 Medical And Biotechnological Services In Sigla M B S Srl Formulazioni farmaceutiche e loro uso per il trattamento della retinite pigmentosa
WO2017172761A1 (en) 2016-03-28 2017-10-05 Allergan, Inc. Phenyl urea derivatives as n-formyl peptide receptor modulators
CN109641857A (zh) 2016-04-12 2019-04-16 阿勒根公司 作为n-甲酰基肽受体调节剂的苯基脲衍生物
ES2943136T3 (es) * 2018-09-27 2023-06-09 Inst Nat Sante Rech Med Polipéptido de TAFA4 para su uso para reducir la inflamación cutánea
GB202404002D0 (en) * 2024-03-20 2024-05-01 Univ Bristol Antimicrobial compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013062947A1 (en) * 2011-10-26 2013-05-02 Allergan, Inc. Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3387948B2 (ja) * 1992-12-04 2003-03-17 富山化学工業株式会社 新規なフェニルアラニン誘導体またはその塩
KR20140145203A (ko) * 2012-04-16 2014-12-22 알러간, 인코포레이티드 포르밀 펩타이드 수용체 2 조절물질로서 (2-우레이도아세트아미도)알킬 유도체
ES2708571T3 (es) * 2013-07-16 2019-04-10 Allergan Inc Derivados de aminoácidos sustituidos con N-urea como moduladores del receptor de péptido formilado
TW201718473A (zh) * 2015-08-05 2017-06-01 歐樂根公司 作為甲醯肽受體１（ｆｐｒ１）選擇性促效劑之苯基脲類似物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013062947A1 (en) * 2011-10-26 2013-05-02 Allergan, Inc. Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators

Also Published As

Publication number Publication date
WO2017023907A1 (en) 2017-02-09
CA2992662A1 (en) 2017-02-09
US20200079729A1 (en) 2020-03-12
AU2020294291A1 (en) 2021-01-28
JP2021178821A (ja) 2021-11-18
JP2018532692A (ja) 2018-11-08
AU2016302146A1 (en) 2018-02-08
JP6900365B2 (ja) 2021-07-07
EP3331897B1 (en) 2021-03-24
TW201718473A (zh) 2017-06-01
EP3331897A1 (en) 2018-06-13

Similar Documents

Publication Publication Date Title
AU2016302146B2 (en) Phenyl urea analogs as formyl peptide receptor 1 (FPR1) selective agonists
AU2012336013C1 (en) Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
AU2014290618B2 (en) Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators
WO2013158597A1 (en) (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
AU2020203420A1 (en) Imidazole derivatives as formyl peptide receptor modulators
AU2014352922B2 (en) Phenylcarbamate derivatives as formyl peptide receptor modulators
WO2015042071A1 (en) Diphenyl urea derivatives as formyl peptide receptor modulators
AU2021261917A1 (en) Phenyl urea derivatives as N-formyl peptide receptor modulators
US11117860B2 (en) Phenyl urea derivatives as n-formyl peptide receptor modulators
US20240025844A1 (en) Phenyl urea analogs as formyl peptide receptor 1 (fpr1) selective agonists
HK1225012B (en) Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators
HK1225012A1 (en) Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ PHENYL UREA ANALOGS AS FORMYL PEPTIDE RECEPTOR 1 (FPR1) SELECTIVE AGONISTS

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired